Literature DB >> 6232199

Cytogenetic investigations in mentally retarded and normal males from 14 families with the fragile site at Xq28. Results of folic acid treatment on fra(X) expression.

K B Nielsen, N Tommerup.   

Abstract

Lymphocyte cultures from 27 mentally retarded males aged 1 year to 77 years, and from 11 normal brothers from a total of 14 families with the fragile X segregating have been examined cytogenetically employing three different culture methods including methods for induction of fra(X) by FUdR (flourodeoxyuridine) or MTX (methotrexate). All mentally retarded males showed unequivocal fra(X) expression. No statistically significant correlation between fra(X) expression and age could be demonstrated. No enhancement with FUdR was observed. Fibroblast cultures from 10 retarded males expressed fra(X) in a dose-response relationship to increasing concentrations of FUdR. None of the normal males showed fra(X). In vivo folic acid treatment of seven mentally retarded males resulted in marked reduction in fra(X) expression in lymphocyte cultures grown in medium 199. However, reinduction was achieved by FUdR or MTX, except in one case who temporarily received very high doses of folic acid.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6232199     DOI: 10.1007/bf00286606

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  34 in total

1.  The marker (X) syndrome: a cytogenetic and genetic analysis.

Authors:  S L Sherman; N E Morton; P A Jacobs; G Turner
Journal:  Ann Hum Genet       Date:  1984-01       Impact factor: 1.670

2.  Prenatal diagnosis of X-linked mental retardation with fragile (X) using fetoscopy and fetal blood sampling.

Authors:  T Webb; C M Gosden; C H Rodeck; M A Hamill; P E Eason
Journal:  Prenat Diagn       Date:  1983 Apr-Jun       Impact factor: 3.050

3.  Fragile X demonstrated retrospectively in amniotic cells cultured in low folate medium.

Authors:  L B Nielsen; K B Nielsen; N Tommerup
Journal:  Prenat Diagn       Date:  1983-10       Impact factor: 3.050

4.  The fragile X(q27) form of X-linked mental retardation: FUdR as an inducing agent for fra(X)(q27) expression in lymphocytes, fibroblasts, and amniocytes.

Authors:  R Brookwell; A Daniel; G Turner; J Fishburn
Journal:  Am J Med Genet       Date:  1982-10

5.  Marker X syndrome.

Authors:  P N Howard-Peebles
Journal:  Am J Med Genet       Date:  1983-02

6.  Expression in lymphocyte and fibroblast culture of the fragile X chromosome: a new technical approach.

Authors:  M G Mattei; J F Mattei; I Vidal; F Giraud
Journal:  Hum Genet       Date:  1981       Impact factor: 4.132

7.  X-linked mental retardation, macro-orchidism, and the Xq27 fragile site.

Authors:  G Turner; A Daniel; M Frost
Journal:  J Pediatr       Date:  1980-05       Impact factor: 4.406

8.  Carrier detection and X-inactivation studies in the fragile X syndrome. Cytogenetic studies in 63 obligate and potential carriers of the fragile X.

Authors:  K B Nielsen; N Tommerup; H Poulsen; P Jacobsen; B Beck; M Mikkelsen
Journal:  Hum Genet       Date:  1983       Impact factor: 4.132

9.  The diagnosis and frequency of X-linked conditions in a cohort of moderately retarded males with affected brothers.

Authors:  J Fishburn; G Turner; A Daniel; R Brookwell
Journal:  Am J Med Genet       Date:  1983-04

10.  FUdR induction of the X chromosome fragile site: evidence for the mechanism of folic acid and thymidine inhibition.

Authors:  T W Glover
Journal:  Am J Hum Genet       Date:  1981-03       Impact factor: 11.025

View more
  3 in total

1.  The fragile X mutation does not have any major effect on the expression of the hypoxanthine phosphoribosyltransferase (HPRT) locus in human fibroblasts.

Authors:  A M Steen; S Marcus; S Sahlén; K B Nielsen; B Lambert
Journal:  Hum Genet       Date:  1991-08       Impact factor: 4.132

2.  A set of male monozygotic triplets with schizophrenic psychoses: nature or nurture?

Authors:  C Härnryd; E Jönsson; D Greitz; H Nyman; G Sedvall
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1995       Impact factor: 5.270

3.  The role of fluorinated pyrimidine analogues in the induction of the in vitro expression of the fragile X chromosome.

Authors:  B Vandamme; I Liebaers; L Hens; J L Bernheim; C Roobol
Journal:  Hum Genet       Date:  1988-08       Impact factor: 4.132

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.